- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Benitec Biopharma Ltd
+ Add to WatchlistBNIKF:US
0.0190 USD 0.00000.00%As of 20:10:00 ET on 05/10/2013.
Snapshot for Benitec Biopharma Ltd (BNIKF)
| Open: | - | Day's Range: | - | Volume: | 3,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0190 | 52wk Range: | 0.0050 - 0.0300 | 1-Yr Rtn: | - |
Key Statistics for BNIKF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 1,767 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BNIKF
Company Profile & Key Executives for BNIKF
Benitec Biopharma Ltd. is a medical technology research and development Company. The Company's research focuses on the gene-technology field to find ways to fight cancer causing cells. Benitec's research encompasses a gene silencing technology in mammalian cells.
| Peter FrenchChief Executive Officer | Michael W GrahamChief Scientific Officer |
| Gregory West "Greg"Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BNIKF News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page